| Dr David B Brown, MD | |
|
4747 Main St, Bridgeport, CT 06606-1804 | |
| (203) 372-0649 | |
| (203) 373-0376 |
| Full Name | Dr David B Brown |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 50 Years |
| Location | 4747 Main St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992734545 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 022562 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rehabilitation Associates Inc | 8022905322 | 297 |
News Archive
New research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD), held online this year (21-25 September), shows that having type 1 diabetes (T1D) is associated with a 33% increase in the risk of falls compared with the general population, while having type 2 diabetes (T2D) is associated with a 19% increased risk of falls.
If the federal debt limit is not raised, several governors said as they gathered here on Friday for the semiannual meeting of the National Governors Association, the ensuing default will harm the economy, make it difficult for states to borrow money and delay some of the vital federal payments that states count on for everything from Medicaid to unemployment benefits.
Gene variations may raise the risk that survivors of childhood cancer will suffer congestive heart failure as a complication of drugs they received during cancer treatment.
Regado Biosciences, Inc., a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications, today announced the enrollment of the first patient in its REGULATE-PCI clinical trial.
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
› Verified 4 days ago
| Entity Name | South-west Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699703686 PECOS PAC ID: 2466445200 Enrollment ID: O20040420001098 |
News Archive
New research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD), held online this year (21-25 September), shows that having type 1 diabetes (T1D) is associated with a 33% increase in the risk of falls compared with the general population, while having type 2 diabetes (T2D) is associated with a 19% increased risk of falls.
If the federal debt limit is not raised, several governors said as they gathered here on Friday for the semiannual meeting of the National Governors Association, the ensuing default will harm the economy, make it difficult for states to borrow money and delay some of the vital federal payments that states count on for everything from Medicaid to unemployment benefits.
Gene variations may raise the risk that survivors of childhood cancer will suffer congestive heart failure as a complication of drugs they received during cancer treatment.
Regado Biosciences, Inc., a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications, today announced the enrollment of the first patient in its REGULATE-PCI clinical trial.
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David B Brown, MD 4747 Main St, Bridgeport, CT 06606-1804 Ph: (203) 372-0649 | Dr David B Brown, MD 4747 Main St, Bridgeport, CT 06606-1804 Ph: (203) 372-0649 |
News Archive
New research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD), held online this year (21-25 September), shows that having type 1 diabetes (T1D) is associated with a 33% increase in the risk of falls compared with the general population, while having type 2 diabetes (T2D) is associated with a 19% increased risk of falls.
If the federal debt limit is not raised, several governors said as they gathered here on Friday for the semiannual meeting of the National Governors Association, the ensuing default will harm the economy, make it difficult for states to borrow money and delay some of the vital federal payments that states count on for everything from Medicaid to unemployment benefits.
Gene variations may raise the risk that survivors of childhood cancer will suffer congestive heart failure as a complication of drugs they received during cancer treatment.
Regado Biosciences, Inc., a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications, today announced the enrollment of the first patient in its REGULATE-PCI clinical trial.
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
› Verified 4 days ago
Dr. Patrick James Carolan, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3909 Main St, Bridgeport, CT 06606 Phone: 203-372-4565 Fax: 203-372-1585 | |
Dr. Donald Sauin Dworken, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3180 Main St, Bridgeport, CT 06606 Phone: 203-372-7678 Fax: 203-372-0587 | |
Dr. Allen P Schlein, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 650 Clinten Avenue, Bridgeport, CT 06605 Phone: 203-336-3526 Fax: 203-335-2968 | |
Dr. Eric J. Katz, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3180 Main St, Suite 107, Bridgeport, CT 06606 Phone: 203-371-4424 Fax: 203-371-4828 | |
Thomas A Rago, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3101 Main Street, Bridgeport, CT 06606 Phone: 203-374-5892 Fax: 203-374-5822 |